Literature DB >> 8878013

Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction.

R P Rabinowitz1, L C Lai, K Jarvis, T K McDaniel, J B Kaper, K D Stone, M S Donnenberg.   

Abstract

An unusual mutant of enteropathogenic E. coli (EPEC), deficient in its ability to invade host cells, was evaluated. The gene interrupted by the transposon in this mutant was located within a region of the EPEC chromosome devoted to secretion of proteins required for signal transduction. The mutant did not secrete detectable levels of the EspB protein, previously shown to be required for attaching and effacing, and did not induce detectable tyrosine phosphorylation of a 90 kDa host cell protein, previously associated with attaching and effacing and invasion. No quantitative or qualitative defect in the ability of the mutant to induce attaching and effacing effects was observed. Moreover, attaching and effacing by wild-type EPEC was unaffected by high doses of the tyrosine kinase inhibitor genistein. These results indicate that attaching and effacing activity can occur in the absence of detectable EspB secretion and tyrosine kinase mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878013     DOI: 10.1006/mpat.1996.0051

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

1.  Tir tyrosine phosphorylation and pedestal formation are delayed in enteropathogenic Escherichia coli sepZ::TnphoA mutant 30-5-1(3).

Authors:  R Devinney; I Nisan; S Ruschkowski; I Rosenshine; B B Finlay
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system.

Authors:  Kristen J Kanack; J Adam Crawford; Ichiro Tatsuno; Mohamed A Karmali; James B Kaper
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells.

Authors:  K A Taylor; C B O'Connell; P W Luther; M S Donnenberg
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 4.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

5.  Expression of the EspB protein of enteropathogenic Escherichia coli within HeLa cells affects stress fibers and cellular morphology.

Authors:  K A Taylor; P W Luther; M S Donnenberg
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Agents that inhibit Rho, Rac, and Cdc42 do not block formation of actin pedestals in HeLa cells infected with enteropathogenic Escherichia coli.

Authors:  G Ben-Ami; V Ozeri; E Hanski; F Hofmann; K Aktories; K M Hahn; G M Bokoch; I Rosenshine
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

7.  A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells.

Authors:  L C Lai; L A Wainwright; K D Stone; M S Donnenberg
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Enteropathogenic Escherichia coli O103 from rabbit elicits actin stress fibers and focal adhesions in HeLa epithelial cells, cytopathic effects that are linked to an analog of the locus of enterocyte effacement.

Authors:  J De Rycke; E Comtet; C Chalareng; M Boury; C Tasca; A Milon
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 9.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

10.  Differential modulation by Ca2+ of type III secretion of diffusely adhering enteropathogenic Escherichia coli.

Authors:  Tina Ide; Silke Michgehl; Sabine Knappstein; Gerhard Heusipp; M Alexander Schmidt
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.